Cargando…
Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
In Japan, 1.5–2 million people are chronically infected with hepatitis C virus (HCV) infection. New direct-acting antiviral agents (DAA) offer an unprecedented opportunity to cure HCV. While the price of HCV treatment decreased recently in most countries, it remains one of the highest in Japan. Our...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058050/ https://www.ncbi.nlm.nih.gov/pubmed/32139872 http://dx.doi.org/10.1038/s41598-020-60986-4 |